Pharmacogenetics: ethnicity, treatment and health in Latin American populations.

Abstract

The Ibero-American Network of Pharmacogenetics and Pharmacogenomics (RIBEF) studies Latin American populations to benefit from the implementation of personalized medicine. Since 2006, it hasstudied ethnicity to apply pharmacogenetics knowledge in autochthonous populations of Latin America, considering ancestral medicine. The meeting 'Pharmacogenetics: ethnicity, Treatment and Health in Latin American Populations'was held in Mexico City, Mexico, and presented the relevance of RIBEF collaboration with Latin American researchers and the governments of Mexico, Spain and the Autonomous Community of Extremadura. The results of 17years of uninterrupted work byRIBEF, the Declaration of Mérida/T'Hóand the call for the DrJosé María CantúAward for studies focused on the pharmacogenetics of native populations in Latin America were presented.